Three decades later, we are still teasing apart the details of this crucial physiological mechanism, now responsible for some of the most popular drugs in the world
Retatrutide is the next pipeline drug that could redefine what weight-loss medications can achieve
Second, if you're weighing compounded versus brand-name, the regulatory trajectory is part of that math, because an FDA-approved brand-name product isn't subject to the same compounding uncertainty
Preclinical and clinical data, though predominantly derived from case reports and small cohort studies to date, consistently indicate that GLP-1 RAs - including liraglutide, semaglutide, and the dual GIP/GLP-1 RA tirzepatide - can induce clinically meaningful weight loss, suppress the characteristic severe hyperphagia, and improve key cardiometabolic parameters in both heterozygous and homozygous MC4R variant carriers